WeVote
Log In

Bill

Bill

SB 778

Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

2026 Regular Session Introduced by Brian Feldman

SB 778 establishes licensing rules for clinical research pharmacies in Maryland while redefining pharmacy scope in trials and clarifying when such work constitutes medical practice.

Approved by the Governor - Chapter 206
0
WeVote Research Nonpartisan
Bill Summary · SB 778

Legislative bill overview

SB 778 modifies Maryland's regulatory framework for clinical research pharmacies by establishing new permitting requirements, clarifying ownership rules, and defining what activities constitute the "practice of medicine" in the clinical trial context. The bill appears designed to create a clearer legal pathway for pharmacies to participate in clinical research while maintaining appropriate regulatory oversight.

Why is this important

Clinical trials are essential for developing new medications and treatments, but regulatory ambiguity can slow research participation and drug development. By clarifying the rules for research pharmacies, this bill could streamline clinical trial operations in Maryland, potentially attracting research activity and improving patient access to experimental treatments. However, it also raises questions about pharmacy scope of practice and patient safety oversight.

Potential points of contention

  • Scope creep concerns: Expanding what pharmacies can do in clinical settings may blur traditional lines between pharmacy practice and medical practice, creating tension with physicians and medical boards
  • Patient safety oversight: New permitting structures must ensure adequate quality controls and patient protections in experimental drug handling and distribution
  • Ownership structure implications: Changes to ownership rules could affect whether non-pharmacist entities can control research pharmacies, raising concerns about profit-driven vs. patient-centered operations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.